{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:14:07Z","timestamp":1783905247459,"version":"3.55.0"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Aim<\/jats:bold>\n                    : The present study aimed to investigate the effectiveness of PRF in the treatment of infrabony defects in patients with chronic periodontitis by evaluating the clinical outcome through periodontal depth, clinical attachment level at the baseline, 6 and 9 months post operatively.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Material and Methods<\/jats:bold>\n                    : Sixty infrabony defects with probing depth \u2265 5 mm were treated. The inclusion criterion was the necessity for surgical bilateral maxillary treatment. By using split-mouth study design, each patient had one side treated with conventional flap surgery and the other side with conventional flap surgery and PRF. Clinical parameters, such as probing depth (PD) and clinical attachment lost (CAL), were recorded in both groups at baseline, 6 and 9 months post operatively.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : Positive effects for all clinical and radiographic parameters were evident in the group with PRF. Mean PD reduction demonstrated statistically significant greater results in the test group (4.00\u00b11.07 mm) compared to the control one (4.83\u00b10.99 mm), p = 0.003 after 9 months postoperatively. After 9 months, there were better results in the test group compared to the control group for CAL (5.60\u00b11.61 mm, 6.20\u00b11.58 mm), but statistically not significant.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    : Additional use of PRF in the conventional surgical treatment of infrabony defects demonstrated better parameters than the open flap debridement alone.\n                  <\/jats:p>","DOI":"10.2478\/prilozi-2020-0025","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T06:17:56Z","timestamp":1592893076000},"page":"79-86","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of PRF Efficiency in the Treatment of Infrabony Defects"],"prefix":"10.2478","volume":"41","author":[{"given":"Jana","family":"Milutinovic","sequence":"first","affiliation":[{"name":"University Clinical Centre \u201cSt. Pantelejmon\u201d, University Ss. Cyril and Methodius , Faculty of Dentistry , Skopje , R.N. Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Popovska","sequence":"additional","affiliation":[{"name":"University Clinical Centre \u201cSt. Pantelejmon\u201d, University Ss. Cyril and Methodius , Faculty of Dentistry , Skopje , R.N. Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Rusevska","sequence":"additional","affiliation":[{"name":"University Clinical Centre \u201cSt. Pantelejmon\u201d, University Ss. Cyril and Methodius , Faculty of Dentistry , Skopje , R.N. Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Nacevski","sequence":"additional","affiliation":[{"name":"University Clinical Centre \u201cSt. Pantelejmon\u201d, University Ss. Cyril and Methodius , Faculty of Dentistry , Skopje , R.N. Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Anastasovski","sequence":"additional","affiliation":[{"name":"University Clinical Centre \u201cSt. Pantelejmon\u201d, University Ss. Cyril and Methodius , Faculty of Dentistry , Skopje , R.N. Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Ivan\u043evska-Stojanoska","sequence":"additional","affiliation":[{"name":"University Clinical Centre \u201cSt. Pantelejmon\u201d, University Ss. Cyril and Methodius , Faculty of Dentistry , Skopje , R.N. Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"2026071211285150516_j_prilozi-2020-0025_ref_001_w2aab3b7c16b1b6b1ab1ab1Aa","doi-asserted-by":"crossref","unstructured":"1. Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV. Novel host response therapeutic approaches to treatperiodontal diseases. Periodontol 2000 2007; 43: 294\u2013315.10.1111\/j.1600-0757.2006.00166.x257032117214846","DOI":"10.1111\/j.1600-0757.2006.00166.x"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_002_w2aab3b7c16b1b6b1ab1ab2Aa","doi-asserted-by":"crossref","unstructured":"2. Wang ZS, Feng ZH, Wu GF, Bai SZ, Dong Y, Chen FM, et al. The use of platelet\u2013rich fibrin combined with periodontal ligament and jaw bone mesenchymal stem cell sheets for periodontal tissue engineering. Sci Rep. 2016; 6: 28126.10.1038\/srep28126491493927324079","DOI":"10.1038\/srep28126"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_003_w2aab3b7c16b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. Kim TH, Kim SH, Sandor GK, Kim YD. Comparison of platelet\u2013rich plasma (PRP), platelet\u2013rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit\u2013skull defect healing. Arch Oral Biol. 2014; 59: 550\u201310.1016\/j.archoralbio.2014.02.00424667430","DOI":"10.1016\/j.archoralbio.2014.02.004"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_004_w2aab3b7c16b1b6b1ab1ab4Aa","unstructured":"4. Choukroun J, Adda F, Schoeffler C, Vervelle A. PRF: An opportunity in perio\u2013implantology. Implantodontie. 2001; 42: 55\u201362."},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_005_w2aab3b7c16b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. Dohan Ehrenfest DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet\u2013rich fibrin (PRF): A second\u2013generation platelet concentrate. Part III: Leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101: 51\u20135.10.1016\/j.tripleo.2005.07.01016504851","DOI":"10.1016\/j.tripleo.2005.07.010"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_006_w2aab3b7c16b1b6b1ab1ab6Aa","doi-asserted-by":"crossref","unstructured":"6. Dohan Ehrenfest DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet\u2013rich fibrin (PRF): A second\u2013generation platelet concentrate. Part II: Platelet\u2013related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101: 45\u201350.10.1016\/j.tripleo.2005.07.00916504850","DOI":"10.1016\/j.tripleo.2005.07.009"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_007_w2aab3b7c16b1b6b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"7. Desai, C.B., et al.Use of Platelet\u2013Rich Fibrin over Skin Wounds: Modified Secondary Intention Healing. J Cutan Aesthet Surg, 2013. 6(1): p. 35\u20137.10.4103\/0974-2077.110096366317523723604","DOI":"10.4103\/0974-2077.110096"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_008_w2aab3b7c16b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. Martinez CE, Smith PC, Palma VA. The influence of platelet\u2013derived products on angiogenesis and tissue repair: A concise update. Front Physiol. 2015; 6: 290.10.3389\/fphys.2015.00290461113626539125","DOI":"10.3389\/fphys.2015.00290"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_009_w2aab3b7c16b1b6b1ab1ab9Aa","doi-asserted-by":"crossref","unstructured":"9. Pradeep AR, Rao NS, Agarwal E, Bajaj P, Kumari M, Naik SB. Comparative evaluation of autologous platelet\u2013rich fibrin and platelet\u2013rich plasma in the treatment of 3 wall intrabony defects in chronic periodontitis: A randomized controlled clinical trial. J Periodontol. 2012; 83: 1499\u20131507.10.1902\/jop.2012.11070522348695","DOI":"10.1902\/jop.2012.110705"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_010_w2aab3b7c16b1b6b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. Mathur A, Bains VK, Gupta V, Jhingran R, Singh GP. Evaluation of intrabony defects treated with platelet\u2013rich fibrin or autogenous bone graft: A comparative analysis. Eur J Dent. 2015; 9: 100\u20138.10.4103\/1305-7456.149653431928425713492","DOI":"10.4103\/1305-7456.149653"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_011_w2aab3b7c16b1b6b1ab1ac11Aa","unstructured":"11. Gupta SJ, Jhingran R, Gupta V, Bains VK, Madan R, Rizvi I. Efficacy of platelet\u2013rich fibrin vs. enamel matrix derivative in the treatment of periodontal intrabony defects: A clinical and cone beam computed tomography study. J Int Acad Periodontol. 2014; 16: 86\u201396."},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_012_w2aab3b7c16b1b6b1ab1ac12Aa","unstructured":"12. Ajwani H, Shetty S, Gopalakrishnan D, Kathariya R, Kulloli A, Dolas RS, et al. Comparative evaluation of platelet\u2013rich fibrin biomaterial and open flap debridement in the treatment of two and three wall intrabony defects. J Int Oral Health. 2015; 7: 32\u20137."},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_013_w2aab3b7c16b1b6b1ab1ac13Aa","doi-asserted-by":"crossref","unstructured":"13. Dangaria SJ, Ito Y, Walker C, Druzinsky R, Luan X, Diekwisch TG. Extracellular matrix\u2013mediated differentiation of periodontal progenitor cells. Differentiation 2009; 78: 79\u201390.10.1016\/j.diff.2009.03.005274484519433344","DOI":"10.1016\/j.diff.2009.03.005"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_014_w2aab3b7c16b1b6b1ab1ac14Aa","doi-asserted-by":"crossref","unstructured":"14. Peker E, Karaca IR, Yildirim B. Experimental evaluation of the effectiveness of demineralized bone matrix and collagenated heterologous bone grafts used alone or in combination with platelet\u2013rich fibrin on bone healing in sinus floor augmentation. Int J Oral Maxillofac Implants. 2016; 31: e24\u201331.10.11607\/jomi.441427004298","DOI":"10.11607\/jomi.4414"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_015_w2aab3b7c16b1b6b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. Bigham AS, Dehghani SN, Shafiei Z, Nezhad ST. Xenogenic demineralized bone matrix and fresh autogenous cortical bone effects on experimental bone healing: Radiological, histopathological and biomechanical evaluation. J Orthopaed Traumatol. 2008; 9: 73\u201380.10.1007\/s10195-008-0006-6265695719384620","DOI":"10.1007\/s10195-008-0006-6"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_016_w2aab3b7c16b1b6b1ab1ac16Aa","unstructured":"16. Richard J. Miron, Giovanni Zucchelli, Michael A. Pikos, Maurice Salama, Samuel Lee, Vincent Guillemette, Masako Fujioka\u2013Kobayashi, Mark Bishara, Yufeng Zhang, Hom\u2013Lay Wang, Fatiha Chandad, Cleopatra Nacopoulos, Alain Simon-pieri, Alexandre Amir Aalam, Pietro Felice, Gilberto Sammartino, Shahram Ghanaati, Maria A Hernandez, Joseph Choukroun. Use of platelet\u2013rich fibrin inregenerative dentistry: asystematic review.Clin Oral Invest 2017."},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_017_w2aab3b7c16b1b6b1ab1ac17Aa","doi-asserted-by":"crossref","unstructured":"17. Marco Del Corso, Alain Vervelle, Alain Simon-pieri, Ryo Jimbo, Francesco Inchingolo, Gilberto Sammartino, David M. Dohan Ehrenfest. Current Knowledge and Perspectives for the Use of Platelet\u2013Rich Plasma (PRP) and Platelet\u2013Rich Fibrin (PRF) in Oral and Maxillofacial Surgery Part 1: Periodontal and Dentoalveolar Surgery. Current Pharmaceutical Biotechnology, 2012, 13, 1207\u20131230 1207 1873\u2013431610.2174\/13892011280062439121740371","DOI":"10.2174\/138920112800624391"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_018_w2aab3b7c16b1b6b1ab1ac18Aa","unstructured":"18. Camargo, P.M.; Lekovic, V.; Weinlaender, M.; Vasilic, N.; Madzarevic, M.; Kenney, E.B. A reentry study on the use of bovine porous bone mineral, GTR, and platelet\u2013rich plasma in the regenerative treatment of intrabony defects in humans. Int. J. PeriodonticsRestorative Dent., 2005, 25(1), 49\u201359."},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_019_w2aab3b7c16b1b6b1ab1ac19Aa","doi-asserted-by":"crossref","unstructured":"19. Lekovic, V.; Camargo, P.M.; Weinlaender, M.; Vasilic, N.; Aleksic, Z.; Kenney, E.B. Effectiveness of a combination of plateletrich plasma, bovine porous bone mineral and guided tissue regeneration in the treatment of mandibular grade II molar furcations in humans. J. Clin. Periodontol., 2003, 30(8), 746\u2013751.10.1034\/j.1600-051X.2003.00368.x12887344","DOI":"10.1034\/j.1600-051X.2003.00368.x"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_020_w2aab3b7c16b1b6b1ab1ac20Aa","doi-asserted-by":"crossref","unstructured":"20. Camargo, P.M.; Lekovic, V.; Weinlaender, M.; Vasilic, N.; Madzarevic, M.; Kenney, E.B. Platelet\u2013rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J. Periodontal Res.,2002, 37(4), 300\u2013306.10.1034\/j.1600-0765.2002.01001.x12200975","DOI":"10.1034\/j.1600-0765.2002.01001.x"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_021_w2aab3b7c16b1b6b1ab1ac21Aa","doi-asserted-by":"crossref","unstructured":"21. Yu\u2013Chao Chang, Kuo\u2013Chin Wu, Jiing\u2013Huei Zhao. Clinical application of platelet\u2013rich fibrin as the solegrafting material in periodontal intra-bony defects. Journa of Dental Science 2011; 6. 181\u2013182.10.1016\/j.jds.2011.05.010","DOI":"10.1016\/j.jds.2011.05.010"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_022_w2aab3b7c16b1b6b1ab1ac22Aa","doi-asserted-by":"crossref","unstructured":"22. Sharma A, Pradeep AR. Treatment of 3\u2013wall intrabony defects in patients with chronic periodontitis with autologous platelet\u2013rich fibrin: a randomized controlled clinical trial.J Periodontol. 2011 Dec; 82(12): 1705\u201312.10.1902\/jop.2011.11007521513477","DOI":"10.1902\/jop.2011.110075"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_023_w2aab3b7c16b1b6b1ab1ac23Aa","doi-asserted-by":"crossref","unstructured":"23. Rosamma Joseph, Arun Raghunatha, Nitin Sharmab. Clinical effectiveness of autologous platelet rich fibrin in the management of infrabony periodontal defects. Singapore Dental Journal 33(2012) 5\u201312.10.1016\/j.sdj.2012.10.00323739317","DOI":"10.1016\/j.sdj.2012.10.003"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_024_w2aab3b7c16b1b6b1ab1ac24Aa","doi-asserted-by":"crossref","unstructured":"24. Bajaj P, Pradeep AR, Agarwal E, Rao NS. Comparative evaluation of autologous platelet\u2013rich fibrin and platelet\u2013rich plasma in the treatment of mandibular degree II furcation defects: a randomized controlled clinical trial. J Periodont Res. 2013; 48 (5): 541\u2013676.10.1111\/jre.1204023317096","DOI":"10.1111\/jre.12040"},{"key":"2026071211285150516_j_prilozi-2020-0025_ref_025_w2aab3b7c16b1b6b1ab1ac25Aa","doi-asserted-by":"crossref","unstructured":"25. Yang LC, Hu SW, Yan M, Yang JJ, Tsou SH, Lin YY. Antimicrobial activity of platelet\u2013rich plasma and other plasma preparations against periodontal pathogens. J Periodontol. 2015; 86: 310\u20138.10.1902\/jop.2014.14037325345340","DOI":"10.1902\/jop.2014.140373"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/prilozi\/41\/1\/article-p79.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2020-0025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:47:11Z","timestamp":1783903631000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2020-0025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,6,22]]},"published-print":{"date-parts":[[2020,6,1]]}},"alternative-id":["10.2478\/prilozi-2020-0025"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2020-0025","relation":{},"ISSN":["1857-8985","1857-9345"],"issn-type":[{"value":"1857-8985","type":"electronic"},{"value":"1857-9345","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}